Principal Financial Group
EWTX icon

Principal Financial Group’s Edgewise Therapeutics EWTX Stock Holding History

Principal Financial Group’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+5,470
New +$189K ﹤0.01% 2076
2024
Q3 		– Sell
-13,084
Closed -$236K – 2288
2024
Q2 		$236K Sell
13,084
-3,681
-22% -$64.2K ﹤0.01% 2112
2024
Q1 		$306K Buy
16,765
+365
+2% +$5.8K ﹤0.01% 2084
2023
Q4 		$179K Sell
16,400
-1,161
-7% -$8.15K ﹤0.01% 2187
2023
Q3 		$101K Buy
17,561
+1,479
+9% +$10.1K ﹤0.01% 2281
2023
Q2 		$125K Buy
16,082
+3,904
+32% +$32.9K ﹤0.01% 2256
2023
Q1 		$81.2K Buy
12,178
+1,230
+11% +$11.4K ﹤0.01% 2327
2022
Q4 		$97.9K Buy
+10,948
New +$103K ﹤0.01% 2297

Other funds holding EWTX

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Principal Financial Group's EWTX Position: Q2 2026 in Review

Principal Financial Group opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 5,470 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #2076 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in EWTX as recently as Q2 2024.

Principal Financial Group first reported a position in EWTX in Q4 2022 and has held it in 8 quarters since. The position peaked at $306K in Q1 2024. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Principal Financial Group held 5,470 shares of Edgewise Therapeutics worth $222K as of Q2 2026.
  • Edgewise Therapeutics was a new Principal Financial Group position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2076 holding.
  • Principal Financial Group first reported a position in Edgewise Therapeutics in Q4 2022 and has held it in 8 quarters since.
  • Principal Financial Group's Edgewise Therapeutics position peaked at $306K in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.